OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
300054$76.8460

Hubei Dinglong Co Ltd

Specialty ChemicalsVerified

Hubei Dinglong Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.48, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 3.17, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow of 142.32 million CNY is significantly lower than its operating cash flow of 1.16 billion CNY, indicating that capital expenditures are consuming a large portion of its operating cash. In terms of profitability, Hubei Dinglong Co Ltd reports a return on equity (ROE) of 13.84% and a return on assets (ROA) of 7.94%. These figures are relatively strong, but the company's price-to-earnings (P/E) ratio of 101.15 and enterprise value-to-EBITDA (EV/EBITDA) ratio of 83.08 suggest that the stock is trading at a premium compared to its earnings and cash flow. The company's gross profit margin of 50.63% (1.85 billion CNY gross profit on 3.66 billion CNY revenue) is robust, but its operating margin of 24.79% (907.05 million CNY operating income) indicates that operating expenses are consuming a significant portion of gross profit. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements. There is no geographic diversification data provided, but the company's operations are primarily based in China, which may expose it to regional economic and regulatory risks. The company's revenue of 3.66 billion CNY is derived from a single product line, which could pose a concentration risk if demand for its products declines. Looking ahead, the company's revenue is expected to grow, but the exact growth rate is not specified in the available data. The company's capital expenditures of 775.37 million CNY are substantial, which may indicate a focus on expansion or modernization. However, the company's free cash flow is relatively low, which may limit its ability to fund future growth initiatives without external financing. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key risk flag is the negative net cash position after subtracting total debt, which could impact the company's ability to meet its short-term obligations. The company's liquidity position is further supported by its current ratio of 3.17, but the negative net cash position suggests that the company may need to access external financing to maintain its operations. Recent events and disclosures indicate that the company has a strong analyst following, with a mean price target of 46.65 CNY and a mean recommendation of 1.43 (1=strong buy, 5=strong sell). The company has received four strong-buy ratings and three buy ratings, with no hold ratings, suggesting that analysts are generally optimistic about its future performance. However, the company's current market price of 76.84 CNY is significantly higher than the mean price target, which may indicate that the stock is overvalued.

30-day price · 300054+23.48 (+47.4%)
Low$49.18High$80.33Close$72.98As of21 May, 00:00 UTC
Profile
CompanyHubei Dinglong Co Ltd
Ticker300054.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Hubei Dinglong Co Ltd is a specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Hubei Dinglong Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.48, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 3.17, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow of 142.32 million CNY is significantly lower than its operating cash flow of 1.16 billion CNY, indicating that capital expenditures are consuming a large portion of its operating cash. In terms of profitability, Hubei Dinglong Co Ltd reports a return on equity (ROE) of 13.84% and a return on assets (ROA) of 7.94%. These figures are relatively strong, but the company's price-to-earnings (P/E) ratio of 101.15 and enterprise value-to-EBITDA (EV/EBITDA) ratio of 83.08 suggest that the stock is trading at a premium compared to its earnings and cash flow. The company's gross profit margin of 50.63% (1.85 billion CNY gross profit on 3.66 billion CNY revenue) is robust, but its operating margin of 24.79% (907.05 million CNY operating income) indicates that operating expenses are consuming a significant portion of gross profit. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements. There is no geographic diversification data provided, but the company's operations are primarily based in China, which may expose it to regional economic and regulatory risks. The company's revenue of 3.66 billion CNY is derived from a single product line, which could pose a concentration risk if demand for its products declines. Looking ahead, the company's revenue is expected to grow, but the exact growth rate is not specified in the available data. The company's capital expenditures of 775.37 million CNY are substantial, which may indicate a focus on expansion or modernization. However, the company's free cash flow is relatively low, which may limit its ability to fund future growth initiatives without external financing. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key risk flag is the negative net cash position after subtracting total debt, which could impact the company's ability to meet its short-term obligations. The company's liquidity position is further supported by its current ratio of 3.17, but the negative net cash position suggests that the company may need to access external financing to maintain its operations. Recent events and disclosures indicate that the company has a strong analyst following, with a mean price target of 46.65 CNY and a mean recommendation of 1.43 (1=strong buy, 5=strong sell). The company has received four strong-buy ratings and three buy ratings, with no hold ratings, suggesting that analysts are generally optimistic about its future performance. However, the company's current market price of 76.84 CNY is significantly higher than the mean price target, which may indicate that the stock is overvalued.
Key takeaways
  • Hubei Dinglong Co Ltd has a strong gross profit margin but a moderate operating margin, indicating that operating expenses are a significant cost driver.
  • The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.48.
  • The company's liquidity position is medium, with a current ratio of 3.17, but it has a negative net cash position after subtracting total debt.
  • Analysts are generally optimistic about the company's future performance, with a mean price target of 46.65 CNY and a mean recommendation of 1.43.
  • The company's stock is currently trading at a premium, with a P/E ratio of 101.15 and an EV/EBITDA ratio of 83.08.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$3.66B
Gross profit$1.85B
Operating income$907.1M
Net income$720.2M
R&D
SG&A
D&A
SBC
Operating cash flow$1.16B
CapEx-$775.4M
Free cash flow$142.3M
Total assets$9.07B
Total liabilities$3.86B
Total equity$5.21B
Cash & equivalents
Long-term debt$2.51B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$3.66B$907.1M$720.2M$142.3M
FY-1$3.34B$716.4M$520.7M$15.6M
FY-2$2.67B$317.6M$222.0M-$632.6M
FY-3$2.72B$481.0M$390.0M-$86.6M
FY-4$2.36B$288.4M$213.5M-$29.3M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$9.07B$5.21B
FY-1$7.39B$4.50B
FY-2$6.71B$4.47B
FY-3$5.62B$4.21B
FY-4$5.11B$4.03B
PeriodOCFCapExFCFSBC
FY0$1.16B-$775.4M$142.3M
FY-1$828.2M-$768.5M$15.6M
FY-2$534.3M-$1.03B-$632.6M
FY-3$562.8M-$676.1M-$86.6M
FY-4$3.1M-$372.2M-$29.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$1.02B$297.8M$251.0M
FQ-1$961.8M$243.0M$200.8M
FQ-2$966.5M$257.7M$208.4M
FQ-3$907.6M$222.9M$170.0M
FQ-4$823.9M$183.5M$141.0M
FQ-5$911.9M$185.6M$144.4M
FQ-6$906.9M$216.5M$158.5M
FQ-7$810.8M$189.7M$136.3M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$9.88B$5.48B$1.33B
FQ-1$9.07B$5.21B
FQ-2$8.98B$4.97B$1.76B
FQ-3$8.82B$4.81B
FQ-4$7.72B$4.66B$1.19B
FQ-5$7.39B$4.50B
FQ-6$7.22B$4.34B$1.08B
FQ-7$6.96B$4.18B
PeriodOCFCapExFCFSBC
FQ0$286.0M-$186.0M
FQ-1$1.16B-$775.4M
FQ-2$770.2M-$660.8M
FQ-3$438.9M-$473.2M
FQ-4$241.4M-$276.2M
FQ-5$828.2M-$768.5M
FQ-6$608.6M-$567.6M
FQ-7$340.8M-$418.8M
Valuation
Market price$76.84
Market cap$72.85B
Enterprise value$75.36B
P/E101.2
Reported non-GAAP P/E
EV/Revenue20.6
EV/Op income83.1
EV/OCF65.2
P/B14.0
P/Tangible book14.0
Tangible book$5.21B
Net cash-$2.51B
Current ratio3.2
Debt/Equity0.5
ROA7.9%
ROE13.8%
Cash conversion1.6%
CapEx/Revenue-21.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300054Activity
Op margin24.8%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin19.7%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin50.6%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-21.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity48.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target46.65 CNY
Median price target46.65 CNY
High price target51.30 CNY
Low price target42.00 CNY
Mean recommendation1.43 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.10 CNY
Last actual EPS0.76 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 01:14 UTCJob: 405fab78